The division of Pediatric Pulmonary and Allergy at the University of Florida is very active in basic, clinical and translational research.
The division has an outstanding track record in asthma research through its collaboration with the College of Pharmacy. Our faculty members have successfully published numerous works studying new asthma therapies, treatment regimens and investigator initiated proofs of concept in asthma management. With the newly established Pediatric Asthma Center of Excellence (PACE), new asthma projects are underway to study protocol driven asthma care and to explore the new field of personalized asthma care.
The division has been recently approved to be a Therapeutic Development Network (TDN) Cystic Fibrosis Center. TDN is a nationwide network of research centers designated by the Cystic Fibrosis Foundation as testing sites for the purpose of facilitating safe, rapid and coordinated evaluation of new treatments for cystic fibrosis.
Our faculty members actively collaborate with other UF departments on several innovative fields of CF research that include studying airway microbiome, new diagnostic methods for detecting airway microbiology and novel therapies targeting calcium chloride channels.
Finally, our division is also involved in gene therapy research, mainly related to effect of retrograde gene therapy on airway patency in mouse model of Pompe’s disease.